Learn More
Selleck Chemical LLC Erdafitinib

Supplier: Selleck Chemical LLC S840125MG
Erdafitinib is a potent and selective orally bioavailable pan fibroblast growth factor receptor (FGFR) inhibitor with potential antineoplastic activity Erdafitinib also binds to RET (c-RET) CSF-1R PDGFR- /PDGFR- FLT4 Kit (c-Kit) and VEGFR-2 and induces cellular apoptosis
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.